Patents by Inventor Jörg Hockemeyer

Jörg Hockemeyer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyridinyl and pyrazinyl-(asa)indolsulfonamides
    Patent number: 11939319
    Abstract: The present invention relates to pyridinyl and pyrazinyl-(aza)indolsulfonamides having GPR17 modulator activity. The compounds have utility in the treatment of a variety of GPR17-associated disorders.
    Type: Grant
    Filed: June 18, 2019
    Date of Patent: March 26, 2024
    Assignee: UCB PHARMA GMBH
    Inventors: Cecile Pegurier, Laurent Provins, Alvaro Cardenas, Marie Ledecq, Christa E. Mueller, Joerg Hockemeyer, Ali El-Tayeb, Nader Boshta, Mahmoud Rashed
  • Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides
    Patent number: 11820746
    Abstract: Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.
    Type: Grant
    Filed: January 5, 2022
    Date of Patent: November 21, 2023
    Assignee: UCB PHARMA GMBH
    Inventors: Christa E. Mueller, Cécile Pegurier, Michael Louis Robert Deligny, Ali El-Tayeb, Joerg Hockemeyer, Marie Ledecq, Joël Mercier, Larurent Provins, Nader M. Boshta, Sanjay Bhattarai, Vigneshwaran Namasivayam, Mario Funke, Lukas Schwach, Sabrina Gollos, Daniel Von Laufenberg, Anaïs Barré
  • Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides
    Publication number: 20230348384
    Abstract: Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.
    Type: Application
    Filed: July 7, 2023
    Publication date: November 2, 2023
    Inventors: Christa E. MUELLER, Cécile PEGURIER, Michael Louis Robert DELIGNY, Ali EL-TAYEB, Joerg HOCKEMEYER, Marie LEDECQ, Joël MERCIER, Larurent PROVINS, Nader M. BOSHTA, Sanjay BHATTARAI, Vigneshwaran NAMASIVAYAM, Mario FUNKE, Lukas SCHWACH, Sabrina GOLLOS, Daniel VON LAUFENBERG, Anaïs BARRÉ
  • N-(PHENYL)-Indole-3-Sulfonamide Derivatives And Related Compounds As GPR17 Modulators For Treating CNS Disorders Such As Multiple Sclerosis
    Publication number: 20220298112
    Abstract: Disclosed are N-(phenyl)-1H-indole-3-sulfonanmide and N-(phenyl)-1H-pyrrolo[2,3-b]pyridine-3-sulfonamide derivatives of formula I substituted at the 1- and 6-positions of the 1H-indole or 1H-pyrrolo[2,3-b]pyridine moiety, as well as structurally related compounds (e.g. the N-pyridin-2-yl and the N-pyridin-3-yl analogues thereof). The present compounds have GPR17 modulating properties which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating disorders such as multiple sclerosis.
    Type: Application
    Filed: June 16, 2020
    Publication date: September 22, 2022
    Inventors: Cécile Pegurier, Silvia Lovera, Christa E. Mueller, Joerg Hockemeyer, Mahmoud Rashed, Ali El-Tayeb, Yong-Qiang Zhang
  • Aza (indole)-, benzothiophene-, and benzofuran-3-sulfonamides
    Patent number: 11345662
    Abstract: Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.
    Type: Grant
    Filed: December 27, 2017
    Date of Patent: May 31, 2022
    Assignee: UCB Pharma GmbH
    Inventors: Christa E. Mueller, Cécile Pegurier, Michael Louis Robert Deligny, Ali El-Tayeb, Joerg Hockemeyer, Marie Ledecq, Joël Mercier, Laurent Provins, Nader M. Boshta, Sanjay Bhattarai, Vigneshwaran Namasivayam, Mario Funke, Lukas Schwach, Sabrina Gollos, Daniel Von Laufenberg, Anaïs Barré
  • Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides
    Publication number: 20220127227
    Abstract: Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.
    Type: Application
    Filed: January 5, 2022
    Publication date: April 28, 2022
    Inventors: Christa E. MUELLER, Cécile PEGURIER, Michael Louis Robert DELIGNY, Ali EL-TAYEB, Joerg HOCKEMEYER, Marie LEDECQ, Joël MERCIER, Larurent PROVINS, Nader M. BOSHTA, Sanjay BHATTARAI, Vigneshwaran NAMASIVAYAM, Mario FUNKE, Lukas SCHWACH, Sabrina GOLLOS, Daniel VON LAUFENBERG, Anaïs BARRÉ
  • Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides
    Publication number: 20220048858
    Abstract: Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.
    Type: Application
    Filed: October 20, 2021
    Publication date: February 17, 2022
    Inventors: Christa E. MUELLER, Cécile PEGURIER, Michael Louis Robert DELIGNY, Ali EL-TAYEB, Joerg HOCKEMEYER, Marie LEDECQ, Joël MERCIER, Larurent PROVINS, Nader M. BOSHTA, Sanjay BHATTARAI, Vigneshwaran NAMASIVAYAM, Mario FUNKE, Lukas SCHWACH, Sabrina GOLLOS, Daniel Von Laufenberg, Anaïs BARRÉ
  • Pyridinyl and Pyrazinyl-(Asa)Indolsulfonamides
    Publication number: 20210206749
    Abstract: The present invention relates to pyridinyl and pyrazinyl-(aza)indolsulfonamides having GPR17 modulator activity. The compounds have utility in the treatment of a variety of GPR17-associated disorders.
    Type: Application
    Filed: June 18, 2019
    Publication date: July 8, 2021
    Inventors: Cecile Pegurier, Laurent Provins, Alvaro Cardenas, Marie Ledecq, Christa E. Mueller, Joerg Hockemeyer, Ali El-Tayeb, Nader Boshta, Mahmoud Rashed
  • Aza (Indole)-, Benzothiophene-, And Benzofuran-3-Sulfonamides
    Publication number: 20190345104
    Abstract: Disclosed are sulfonamide compounds with GPR17 modulating properties, which are useful for treating or preventing a variety of CNS and other diseases, in particular for preventing and treating myelinating diseases or disorders.
    Type: Application
    Filed: December 27, 2017
    Publication date: November 14, 2019
    Applicant: UCB Pharma GmbH
    Inventors: Christa E. MUELLER, Cécile PEGURIER, Michael Louis Robert DELIGNY, Ali EL-TAYEB, Joerg HOCKEMEYER, Marie LEDECQ, Joël MERCIER, Laurent PROVINS, Nader M. BOSHTA, Sanjay BHATTARAI, Vigneshwaran NAMASIVAYAM, Mario FUNKE, Lukas SCHWACH, Sabrina GOLLOS, Daniel von LAUFENBERG, Anaïs BARRÉ
  • 8-alkynylxanthines and derivatives
    Patent number: 8044061
    Abstract: Disclosed are novel compounds of the general formula (Ia), and pharmaceutically acceptable salts, isomers, diastereomers or enantiomers thereof and their use as medicines, for example in the treatment of dopamine-related movement disorders.
    Type: Grant
    Filed: December 21, 2007
    Date of Patent: October 25, 2011
    Assignee: UCB Pharma GmbH
    Inventors: Christa E. Müller, Jörg Hockemeyer, Nikolay T. Tzvetkov, Joachim C. Burbiel